We are CLB

Established in 2016 in Shenzhen, China, Cheerland Biotechnology (CLB) has established business presence in molecular diagnostics, biologics CDMO, and clinical services, aiming to become a leading biotech enterprise in China and the world.


Led by an international team with extensive experiences in biologics manufacturing, CLB provides global biopharma clients with Five-Star CDMO services. We are also building the first Biomanufacturing 4.0 plant in Asia, aiming to become a leader in the upcoming revolution in biologics development and manufacturing.

:: Five-Star CDMO Services »

⭐World-class management & technical team; ⭐Top-line equipment & materials including the first 15kL bioreactors in China; ⭐Robust process design; ⭐Compliance with cGMP standards and global regulatory requirements; ⭐Best cost savings in the industry.

::: Biomedicine for All »

Our mission is to make biomedicine affordable and accessible to worldwide patients through technological innovations and large-scale commercial production. Cheerland Biotechnology, the World’s Local CDMO.

425 KL

Capacity by 2023


BD Customers


Projects under contract

💖 Any questions regarding CLB CDMO services, we’d love to hear from you!

CLB Team

Nobel Prize winner, academician of the American Academy of Sciences. One of the most famous scientists of the twentieth century. He co-discovered the DNA double helix structure in 1953 and won the Nobel Prize in Physiology or Medicine in 1962. He is known as “Einstein of Life Sciences” and “Father of DNA” …»

Extensive experiences in capital investment and business operations in China and abroad. He has established several successful companies in various industries at home and abroad, and has successfully led many cross-border and cross-market transformations of the companies he founded.

Renowned financier and entrepreneur, Dr. Ma is currently the chairman of the board of directors of the Shenzhen International Public Welfare Institute, the executive director of the Chinese Finance Society, and the executive director of the Chinese Business Leaders’ Association. Former director and president of China Merchants Bank; Chairman of the National Science and Technology Achievement Transformation Guidance Fund, among other key positions.

25 years of experiences in international biotech & CDMO. Held various executive, technical, and operational leadership positions in biopharmaceutical companies in the U.S., Asia, and Europe. Former Global Head of Technical Operations at BeiGene, and a founding Executive member and Vice President of Samsung Biologics Manufacturing …»


Our team has been very impressed with the top-tier talent at Cheerland CDMO. I believe our antibody development projects are in good hands with Michael, Travis and their team. They have the required international experience and expertise to help us quickly push our products into clinical stage and beyond. In addition, their large-scale commercial production capacity will become invaluable to us when we enter a very competitive biomedicine market place.

We have been working with CLB for almost a year now, starting with discussions on a wide range of topics related to R&D. They helped us tremendously with process development and overcoming other pre-IND hurdles.  We look forward to working with CLB to produce our first drug for the upcoming clinical trials.